| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915968 | Nuclear Medicine and Biology | 2015 | 6 Pages |
Abstract
123I-IMP metabolite analysis has the potential to provide beneficial information for prediction of the effect of medicines, in addition to its contribution to more accurate rCBF diagnosis that reflects individual CYP activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kodai Nishi, Asuka Mizutani, Naoto Shikano, Ken-ichi Fujita, Masato Kobayashi, Masahiro Ono, Ryuichi Nishii, Yasutuna Sasaki, Seigo Kinuya, Keiichi Kawai,